Third-Line Therapy in Metastatic Colorectal Cancer. Reply

N Engl J Med. 2023 Jul 13;389(2):190-191. doi: 10.1056/NEJMc2306486.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bevacizumab
  • Colorectal Neoplasms* / drug therapy
  • Humans
  • Trifluridine*

Substances

  • tipiracil
  • Trifluridine
  • Bevacizumab